A Study on the Efficacy of GD2-CAR T Cells in the Treatment of Neuroblastoma

NCT06684639 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma

Interventions

BIOLOGICAL: GD2-CAR-T cell

Sponsor

The General Hospital of Western Theater Command

Collaborators

[object Object]